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anhydrase I showed aggravated joint
inflammation and tissue destruction
Yabing Zheng1,2, Lin Wang2, Wei Zhang3, Hengwei Xu4 and Xiaotian Chang1*Abstract
Background: Studies have demonstrated that carbonic anhydrase I (CA1) stimulates calcium salt precipitation and
cell calcification, which is an essential step in new bone formation. Our study had reported that CA1 encoding
gene has a strong association with rheumatoid arthritis (RA) and ankylosing spondylitis (AS), two rheumatic diseases
with abnormal new bone formation and bone resorption in joints. This study investigated the effect of CA1 on joint
inflammation and tissue destruction in transgenic mice that over-express CA1 (CA1-Tg).
Methods: CA1-Tg was generated with C57BL/6J mice by conventional methods. CA1-Tg was treated with
collagen-II to induce arthritis (CIA). Wild-type mice, CA1-Tg treated with bovine serum albumin (BSA) and transgenic
mice over-expressing PADI4 (PADI4-Tg), a gene known to be involved in rheumatoid arthritis, were used as
controls. Histochemistry and X-ray radiographic assay were used to examine joint destruction. Western blotting and
real time-PCR were used to examine CA1 expression.
Results: CIA was observed in 60% of CA1-Tg, 20% of PADI4-Tg and 20% of wild-type mice after collagen injections.
No CIA was found in CA1-Tg mice that received injections of BSA. The arthritic score was 5.5 ± 0.84 in the CA1-Tgs
but the score was less than 2 in the injected wild-type mice and the PADI4-Tgs. The thickness of the hind paws in
the CA1-Tgs was 3.46 ± 0.11 mm, which was thicker than that of PADI4-Tgs (2.23 ± 0.08 mm), wild-type mice
(2.08 ± 0.06 mm) and BSA-treated CA1-Tgs (2.04 ± 0.07 mm). Histochemistry showed obvious inflammation, synovial
hyperplasia and bone destruction in the joints of CA1-Tg that was not detected in PADI4-Tgs or wild-type mice.
X-ray assays showed bone fusion in the paws and spines of CA1-Tg mice.
Conclusion: Over-expression of CA1 may aggravate joint inflammation and tissue destruction in the
transgenic mice.
Keywords: Carbonic anhydrase I (CA1), New bone formation, Transgenic mice, collagen-induced arthritis (CIA),
Ankylosing spondylitis (AS), Rheumatoid arthritis (RA)Background
Abnormal new bone formation and bone resorption are
the most distinctive features of ankylosing spondylitis
(AS) [1-3]. Histopathological experiments have demon-
strated that severe forms of AS correlate significantly
with villous chronic synovitis, including obliterating vas-
cularitis, fibrosclerosis, necrosis and calcification of dis-
integrated synovial structures [4]. Using a proteomic* Correspondence: changxt@126.com
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reproduction in any medium, provided the orapproach, we previously screened novel AS-specific pro-
teins by simultaneously comparing the expression pro-
files of synovial membranes from patients with AS,
rheumatoid arthritis (RA) and osteoarthritis (OA). That
proteomic study revealed significantly increased expres-
sion of carbonic anhydrase I (CA1) in the synovial mem-
brane of AS patients compared with those of RA and
OA patients. Immunohistochemistry and western blot-
ting analyses confirmed the above findings [5]. Further-
more, we also reported that methazolamide, an anti-CA
drug, may improve AS symptoms by a case report [6].
CA1 is a member of the carbonic anhydrase (CA) family,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reactions of CO2/H2CO3 [7]. In vitro assays have
demonstrated that CA1 not only enhances the hydration
reaction but also promotes the formation of CaCO3
[8,9]. Calcium salt precipitation is an important step in
bone formation. Thus, the increased CA1 expression in
the synovium of AS patients may lead to improper
mineralization by accelerating calcium salt deposition
[5]. We recently found that an increased expression of
CA1 stimulates calcium precipitation and ossification in
cultured Saos-2 cells, a human osteosarcoma cell line
[10]. We also found significant association between the
CA1 DNA polymorphism and susceptibility to AS risk
that the gene encoding CA1 is susceptible to AS and RA
risk. However, no study has demonstrated a role for
CA1 over-expression in the processes of new bone for-
mation and bone resorption of joint tissue in physio-
logical condition.
In this study, we generated transgenic mice that over-
expressed CA1 (CA1-Tg) and injected the animals with
collagen II (cII) to induce arthritis (CIA). We examined
the clinical score, arthritic incidence and footpad swel-
ling in CA1-Tg mice, and we used wild-type mice and
transgenic mice that over-express PADI4 (PADI4-Tg), a
gene known to be involved in RA [11], as controls. X-ray
assays and histochemistry were employed to examine
joint destruction in these mice. The purpose of this
study was to use transgenic mice to determine the effect
of CA1 over-expression on joint inflammation and tissue
destruction.
Methods
Generation of transgenic mice that over-expressed CA1
Mouse full-length CA1 cDNA was amplified by reverse
transcription PCR (RT-PCR) using a kit from Invitrogen
(USA) and confirmed by sequencing analysis. The CA1
cDNA was inserted downstream of the CMV promoter
in the pCDNA3.1 (+) vector between the BamHI and
XhoI cloning sites. The completed plasmid was linear-
ized by digestion with endonuclease BglII. The entire
transgenic expression cassette including the CMV pro-
moter, the CA1 full-length cDNA and the BGH polyA
signal was not disrupted. The DNA fragments were gel-
purified, dissolved in Tris–HCl–EDTA at a final concentra-
tion of 5 ng/μl and injected into the pronuclei of fertilized
zygotes harvested from C57BL/6J mice using conventional
methods to generate the transgenic mice [12]. This experi-
ment was completed in Dr. Zhang Lianfeng’s laboratory at
the Institute of Laboratory Animal Science at the Chinese
Academy of Medical Sciences.
The transgenic founder (F0) mice were mated with
wild-type C57BL/6J mice to produce the F1 generation,
and CA1 expression was detected in the F1 transgenic
mice. The F1 transgenic lines were mated with wild-typeC57BL/6J mice to produce F2 mice, which were used for
phenotypic analyses. The wild-type mice were also
obtained from Institute of Laboratory Animal Science at
the Chinese Academy of Medical Sciences. The trans-
genic mice that over-expressed PADI4 were generated in
the same manner.
Mouse genomic DNA was extracted from tail biopsies.
PCR was performed in a 20 μl reaction volume containing
1 μg of genomic DNA and the primers used for cloning
the CA1 gene. The sense primer was 50-GCAAGCTT
CATGAGACCTAGAATGAAGTAT-30, and the antisense
primer was 50-CGGGATCCTTTACTGCATTAGATTTT
CGAG-30. These primers amplify a 374 bp sequence from
the pCMV promoter. The PCR product was examined
using electrophoresis on 1% agarose gel.
Synovial tissues were dissected from CA1-Tg (n = 5),
PADI4-Tg (n = 6) and wild-type (n = 6) mice. CA1
mRNA expression was quantified using real-time PCR.
The thymus, spleen, liver, lungs and kidneys were dis-
sected from CA1-Tg (n = 5), PADI4-Tg (n = 6) and wild-
type mice. The levels of CA1 protein in these organs
were examined using western blotting.
The procedures involving animals were approved by the
Institutional Animal Care and Use Committee of the
Chinese Institute of Laboratory Animal Science (GC-08-
2018), and the mice were housed in an Association for As-
sessment and Accreditation of Laboratory Animal Care
(AAALAC)-accredited facility. The Ethics Committee of
Shandong Provincial Qianfoshan Hospital approved the
study and the protocol.
Collagen-induced arthritis
Bovine collagen type II (cII) (400 μg, Sigma, USA) was
injected into the tails of CA1-Tg (n = 10), PADI4-Tg
(n = 10) and wild-type (n = 10) mice (8 weeks old, male).
CA1-Tg (n = 10) were also treated with bovine serum al-
bumin (BSA) as controls. cII was dissolved overnight at
4°C in 10 mM acetic acid at a concentration 4 mg/ml
and emulsified in an equal volume of complete Freund’s
adjuvant (CFA, Sigma, USA) containing 100 mg heat-
killed (strain H37Ra, Sigma, USA). These mice were
injected with the same dose of cII in incomplete
Freund’s adjuvant (IFA, Sigma) 3 weeks later. The sever-
ity of CIA was determined by monitoring the incidence
of CIA, the clinical score and the thickness of the hind
paws. The incidence was expressed as the percentage of
mice that showed visible symptoms of arthritis. Clinical
scoring was performed using an established scoring sys-
tem as described in Von Delwig’s study [13]. The score
for each paw was based on the degree of swelling and
periarticular erythema using a scale of 0–3 as follows: 0
= no evidence of erythema or swelling, 1 = erythema
confined to one joint region only, 2 = erythema and
swelling limited to one joint region only and 3 = severe
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midfoot (tarsal) joint and involving both joint regions.
Scores from all four paws were added to provide the total
score for each mouse. The maximum possible score per
mouse was 12. The thickness of the hind paws was mea-
sured using vernier calipers (reading error of 0.1 mm,
Mitutoyo, JAP). Control-treated CA1-Tg (n = 10) mice
were administered with BSA.
The development of disease was monitored for the
period indicated. At 120 days after the first injection
with cII, the mice were sacrified, and their paws were
dissected, fixed in 10% formaldehyde (pH 7.4) and then
embedded in paraffin wax. Serial sections (5 mm) of the
joints were prepared and then stained using hematoxylin
to evaluate pannus formation, synovial cell infiltrate and
cartilage/bone erosion.
The data are representative of three independent
experiments. The clinical scores and paw thickness were
analyzed using a two-way analysis of variance. The inci-
dence of CIA was analyzed using Fisher’s exact test.
X-ray radiographic assessment
CA1-Tg mice, wild-type mice, PADI4-Tg mice and CA1-
Tg mice treated with BSA were evaluated at 120 days
after the first injection of CII. The mice were anesthe-
tized and irradiated using a digital mammography X-ray
as described by Zähringer [14]. Digital images of the ver-
tebrae and joints were obtained using the following ex-
posure parameters: mammography film, 23 kV and 32
mAs; Inc, -2; AGD, 0.52 mGy; ESE, 1.36 mGy. This ex-
periment was completed in the Radiological Department
of the Shandong Tumor Hospital.
Real-time PCR
Total RNA was extracted from animal tissues using a total
RNA kit (Omega, USA) according to the manufacturer’s
protocol. The concentrations of total RNA were deter-
mined using a spectrophotometer. The cDNA was pre-
pared with 500 ng of total RNA from each sample using
oligo-dT primers and the PrimeScriptTM RT-PCR Kit
(TaKaRa, Japan). Quantitative PCR analysis was performed
using a LightCycler 480 thermocycler (Roche). Taqman
real-time PCR was conducted in 10 μl reaction mixtures
containing 5 μl of SYBR Green (Toyobo, Japan), 1 μl of
each primer, 1 μl of cDNA and 2 μl of H2O. The opti-
mized thermal cycling program was as follows: step 1,
95°C for 180 s; step 2, 95°C for 10 s, 59°C for 10 s and
72°C for 25 s (45 cycles); and step 3, a melting curve ana-
lysis over 59–95°C in 0.5°C increments. The specificity of
the individual amplification reactions was assessed by
examining the melting curves to confirm the presence of a
single gene-specific peak with the characteristic melting
temperature of the expected product. The primers for
CA1 are as follows: 50-GCTACAGGCTCTTTCAGTT-30and 50-GACTCCATCCACTGTATGTT-30. The PCR
results were normalized to the level of GAPDH expres-
sion. Two reactions were performed simultaneously for
each sample. One reaction was performed to determine
the expression of mRNA of the target gene, and the sec-
ond reaction was performed to determine the level of
GAPDH. The experiment was performed in triplicate, and
the PCR products were confirmed using a melting-curve
analysis. The relative expression of mRNA was calculated
using the comparative threshold cycle (Ct) method
according to the following formula: Ratio =2–ΔΔCt = 2-ΔCt
(sample)-ΔCt(control) where ΔCt = Ct of the target genes – Ct
of the endogenous control gene (GAPDH). The relative
target gene expression was calculated by normalizing to
the expression of GAPDH mRNA. The copy number of
the target mRNA in each sample was calculated automat-
ically using data analysis software. The levels of CA1 are
expressed as the median and range. Significant differ-
ences were assessed using the Mann–Whitney U-test
where p < 0.05 was considered statistically significant.Western blotting
Animal tissues were homogenized in RIPA buffer (Beyo-
time, China) supplemented with protease and phosphatase
inhibitors on ice and centrifuged at 16,000x g for 5 min at
4°C. The supernatant was collected, and the protein con-
centration was determined using the BCA Protein Assay
Kit (Beyotime, China). Thirty micrograms of total protein
was separated on a 12% SDS-polyacrylamide gel and
transferred onto a PVDF membrane. The membrane was
rinsed with wash solution and incubated overnight at 4°C
with anti-human carbonic anhydrase I antibody (Santa
Cruz, USA) at a dilution of 1:500. The antibody was pre-
pared by immunizing a mouse with a peptide comprising
carbonic anhydrase I amino acids 33–80, which are near
to the N-terminus. The manufacturer confirmed no cross-
reactivity with other carbonic anhydrases. Immunosignals
were visualized using the Protein Detector BCIP/NBT
Western Blotting Kit (Beyotime, China) following the
manufacturer’s instructions. The quantification was con-
ducted using ImageQuant 5.2 software. To normalize the
sample loading, a separate membrane was prepared in the
same manner and was probed using an anti-GAPDH anti-
body (Santa Cruz, USA).Statistical analyses
All data are presented as the mean ± SD. Comparisons be-
tween two groups were performed using unpaired Stu-
dent’s t-tests. Multiple intergroup comparisons were
performed using one-way ANOVAs. The incidence of mice
that developed the disease was analyzed using Fisher’s
exact test. We considered p values <0.05 to be significant.
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Generation of CA1-Tg mice
To determine the potential role of CA1 in arthritis and
AS, C57BL/6J transgenic mice that over-expressed CA1
were generated. Five transgenic founders (#1, #2, #4,
#33, and #37) were generated and identified based on a
PCR analysis of their genomic DNA. The transgenic
founder (F0) mice were mated with wild-type C57BL/6J
mice to produce the F1 generation, and the CMV/CA1
gene was identified based on a PCR analysis of their gen-
omic DNA (data not shown). These founder mice did
not show significant differences of phenotype, growth
rate, body weight and fertility among them. All of five
founders were used to generate F2.
CA1 expression in the transgenic mice
CA1 protein levels were determined in the lung, kidney,
spleen, thymus and liver of these transgenic mice (n = 5,
8 weeks old) using western blotting. CA1 protein
(29 kDa) levels were 3.05-fold (p = 0.02) higher in the
spleen, 1.8-fold (p = 0.005) higher in the liver, and 2.04-
fold (p = 0.016) higher in the thymus of CA1-Tg mice
compared with wild-type mice (n = 6, 8 weeks old). The
expression of CA1 was unchanged, low or was not


























Figure 1 The expression of CA1 in various tissues of CA1-Tg mice. (A)
kidneys and lungs of CA1-Tg mice (n = 5), PADI4-Tg mice (n = 6) and wild-t
CA1 were semi-quantified by normalizing the expression of GAPDH in the
synovial tissues of CA1-Tg mice, PADI4-Tg mice and wild-type mice using rthe lungs (p = 0.07) and kidneys (p = 0.767), compared
with controls. The levels of CA1 protein in the various
organs of the PADI4-Tg mice (n = 6, 8 weeks old) were
similar to those of the wild-type mice. These results are
shown in Figure 1A and B.
The level of CA1 mRNA in the synovial tissues of these
F1 mice (n = 5) was quantified using real-time PCR. Com-
pared with the expression of CA1 in synovial samples
from wild-type mice (n = 6) and PADI4-Tg mice (n = 6),
CA1 mRNA was increased 1.85-fold (p = 0.016) in the tis-
sues of CA1-Tg mice. There was no significant difference
in CA1 mRNA level of the synovial membranes between
PADI4-Tg mice and wild-type mice (p = 0.145). These
results are shown in Figure 1C.
Collagen-induced arthritis in transgenic mice over-
expressing CA1
The arthritic incidence and the CIA clinical scores of
CA1-Tg mice were compared with those of PADI4-Tg
mice and wild-type mice. CA1-Tg mice that were injected
with BSA were also used as controls. The incidence of
CIA was 60% (6/10) in CA1-Tg mice, 20% (2/10) in
PADI4-Tg mice, 20% (2/10) in wild-type mice and 0%
(0/10) in CA1-Tg mice injected with BSA on the 84th day




























































The CA1 expression was examined in the spleen, liver, thymus,
ype mice (n = 6) using western blotting. (B) The expression levels of
protein extracts. C. The CA1 mRNA expression level was quantified in




CA1-Tg mice with BSA treatment
CA1-Tg mice with collagen 
injection on the 35th day






CA1-Tg mice with collagen 
injection on the 77th day
CA1-Tg mice with collagen 
injection on the 92nd day
Figure 2 Clinical symptoms of CIA in collagen-injected CA1-Tg mice. The incidence of arthritis (A), clinical scores (B) and hind-paw
thicknesses (C) were measured in CA1-Tg mice (filled squares, n = 10), PADI4-Tg mice (filled circles, n = 10) and wild-type (empty triangle, n = 10)
mice at different time points after the first injection of collagen. CA1-Tg mice that received BSA were also included as a control (empty circles, n
= 10). (D) Evident CIA appeared in the hind paws of CA1-Tg mice. a The collagen-injected CA1-Tg mice on the 35th day after the first injection of
collagen, b collagen-injected CA1-Tg mice on the 77th day, c collagen-injected CA1-Tg mice on the 92nd day, d BSA-treated CA1-Tg mice on the
77th day, e collagen-injected PADI4-Tg mice on the 77th day, and f collagen-injected wild-type mice on the 77th day.
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Tg mice on the 98th day after the first injection, but the
score was less than 2 for the wild-type mice and the
PADI4-Tg mice under the same conditions. No clinical
signs of arthritis were found in the CA1-Tg mice treated
with BSA (p = 0.00001, Figure 2B).
The hind-paw thickness of the CA1-Tg mice was 3.46 ±
0.11 mm, which was thicker than that of PADI4-Tg mice
(2.23 ± 0.08 mm), wild-type mice (2.08 ± 0.06 mm) and
BSA-treated CA1-Tg mice (2.04 ± 0.07 mm; p = 0.00001,
Figure 2C). The hind paws of the CA1-Tg mice showed
significant edema, redness and ankylosis with pronounced
loss of function on the 92nd day after the first injection of
collagen, whereas the hind paws of all immunized PADI4-
Tg mice and wild-type mice appeared normal (Figure 2D).
Five mice were selected randomly from the collagen-
injected CA1-Tg mice with CIA (n = 5), the PADI4-Tgmice (n = 5), the wild-type mice (n = 5) without CIA and
the BSA-treated CA1-Tg mice (n = 5) to examine joint
tissue structure. Histological examination detected evi-
dent cell hyperplasia and diffused lymphoid cell infil-
trate; fibrin deposition; cartilage-surface erosion; and
bone destruction in the joints of the paw, ankle, knee
and sacroilium of all five CA1-Tg mice with CIA. The
joints of the PADI4-Tg mice and the wild-type mice that
were injected with collagen and the CA1-Tg that were
injected with BSA exhibited a smooth articular surface.
No significant synovial inflammation or cartilage surface
erosion was observed in these controls. These results are
shown in Figure 3.
The destruction of the joint tissue described above in
the collagen-treated CA1-Tg mice (n = 5), collagen-
treated PADI4-Tg mice without CIA (n = 5), collagen-
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Figure 3 Histochemical examination of collagen-induced arthritis in CA1-Tg mice. Tissue structures of the paw (A-D), knee (E-H), ankle
(I-L) and sacroiliac joints (M-P) were examined using histochemistry. Synovial hyperplasia and inflammation, cartilage destruction and bone
resorption with pannus formation were detected in the arthritic joints of CA1-Tg mice (n = 5). The single arrow indicates the synovial membrane,
and the double arrow indicates the joint cartilage. Magnification: ×400.
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X-ray imaging. In collagen-treated CA1-Tg mice, the
contours of the cartilaginous tissues were diffuse due to
chondrophyte formation. Progression of spondylitis was
observed in each CA1-Tg animal that developed CIA. In
the three CA1-Tg mice treated with collagen, the disk
space disappeared, and chondrophyte/osteophyte fusion
with the neighboring vertebral bodies was observed that
replaced the original intervertebral disk. In the collagen-
treated PADI4-Tg mice, the wild-type mice and the
BSA-treated CA1-Tg mice, the growth plates were nor-
mal, and the end plates of the vertebral bodies appeared
as sharp, solid lines. In addition, the hind paws of the
injected CA1-Tg mice treated with CIA exhibited bone
formation in the ankle joints. In contrast, the hind paws
of the collagen-immunized PADI4-Tg mice and wild-
type mice as well as the BSA-treated CA1-Tg mice
appeared similar to those of wild-type mice that had not
received any treatment and displayed no apparent bone
formation. These X-ray results are shown Figure 4.The above experiment was repeated for 3 times and
we got similar results. The data are representative of
three independent experiments. All F2 from different
founders were used for the experiment. There was no
significant difference among these F2.
Discussion
In our study, transgenic mice that over-expressed CA1
were markedly susceptible to collagen treatment and
showed a high incidence and serious symptoms of arth-
ritis. X-ray images revealed that the disk space in the
spinal regions had disappeared, that neighboring vertebral
bodies had fused and that the bone density had increased
in the paws and spines of collagen-immunized CA1-Tg
mice. In contrast to CA1-Tg mice, clinical and histological
evaluation showed a normal progression of disease para-
meters in the collagen-immunized wild-type mice and
PADI4-Tg mice. The growth plates were normal in
PADI4-Tg and wild-type mice. Histological examination












L K J I 
H G F E 
D C B 
PADI4-Tg mice with 
injection of collagen 
 
wide-type mice with 
injection of collagen 
 
CA1-Tg mice with 
injection of BSA 
 
CA1-Tg mice with 
injection of collagen 
 
sacrum 
joints   
S3 
Figure 4 X-ray images of joint tissue destruction in the ankle- and lumbar-spine vertebrae of collagen-injected CA1-Tg mice. Evident
bone formation (indicated with an arrow) was observed in the hind paws of immunized CA1-Tg mice (n = 5) (A) but not in the paws of wild-type
mice (n = 5) (B), PADI4-Tg mice (n = 5) (C) or BSA-treated CA1-Tg mice (n = 5) (D). The disk space disappeared, and a chondrophyte/osteophyte
was fused with the neighboring vertebral bodies between L5 and S1 (E) as well as S4 and S5 (I). There was no apparent bone fusion in the
lumbar spine vertebrae of collagen-injected wild-type mice (F, J), PADI4-Tg mice (G, K) or BSA-treated CA1-Tg mice (H, L).
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iliac joints of CA1-Tg mice with CIA but not in the
PADI4-Tg and wild-type mice. Thus, our study suggests
that over-expression of CA1 may accelerate the joint in-
flammation and tissue destruction of the mice.
The inflammation, bone erosion and ossification of
sacroiliac joints and the spine are histopathological fea-
tures of AS [15]. Mark et al. established transgenic mice
that expressed human HLA-B27. Using radiographic and
histological techniques, they detected severe axial skel-
etal kyphosis and ankylosis accompanying an inflamma-
tory and fibrotic process at the end plates and enthesis
[16]. Their observations were similar to the observations
of our animal model. These animals developed a spon-
taneous multisystem disorder that resembles the spon-
dylitis observed in AS. Although the histological featuresof the synovial membranes of the peripheral joints in AS
are similar to those of RA, fibroblastic proliferation, in-
timal cell hypertrophy, diffuse lymphocyte and histiocyte
infiltration and the presence of fibrin were less marked
in the joint tissues of AS than in joint tissues of definite
RA. Decreased intimal cell hypertrophy and fibroblastic
proliferation were observed in synovial tissues of AS
compared with RA [17]. In the synovial tissue of CA1-
Tg mice with CIA, intimal cell hypertrophy and fibro-
blastic proliferation were relatively low and the lining
layer was thin. Thus, the transgenic mice that over-
expressed CA1 showed more AS symptoms than RA
symptoms following treatment with collagen.
Joint tissue destruction is a hallmark of inflammatory
joint diseases, such as RA and AS. Despite considerably
different pathologies, there are certain similarities among
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cartilage destruction are the driving force for the struc-
tural changes in the diseased joints. We recently reported
that the gene encoding CA1 is susceptible to AS and RA
[10]. Thus, it is not surprised that we observed more AS
symptom in CA1-Tg following collagen treatment. CIA is
generally used to investigate mechanism of RA. Gillet
et al. studied 40 inbred female Wistar Furth rats. At
2 weeks after immunization with native human type-II
collagen, the rats showed polyarthritis that progressed to
ankylosis associated with ossifying enthesopathy and peri-
osteal new bone formation. Inflammatory nodules of the
tail appeared after 2 months, with radiological and histo-
pathological aspects of multistage spondylodiscitis [18].
Their finding supports the fact that collagen-induced arth-
ritis may be a relevant model of peripheral and axial ossi-
fying enthesopathy.
In the present study, we did not investigate the site of
genome incorporation of CA1 in the transgenic mice. We
prepared a series of controls including collagen-injected
PADI4-Tg, BSA-injected CA1-Tg and collagen-injected
wild-type. These controls showed low joint inflammation
and no joint inflammation in their joint tissues. The con-
trols also showed normal expression of CA1 in various
organs of the mice. On the other hand, CA1-Tg showed
significant joint inflammation following injection of colla-
gen II. These results suggest that the CMV promoter and
neighboring genes did not put an effect on the CA1 ex-
pression in CA1-Tg and did not take influence on the re-
sult of the study.
Our study had demonstrated that CA1 stimulates cal-
cium salt precipitation and cell calcification which could
explain the higher incidence of the disease in CA1 trans-
genic mice which can explain the joint tissue destruction
[5]. We had also reported that CA1 encoding gene has a
strong association with AS [10]. The present study
detected high expression of CA1 in spleen, thymus and
synovial tissues. But it is not sure if CA1 has any effect
on adaptive immune response which could also explain
the higher incidence of the disease in CA1 transgenic
mice. Recently, Yamanishi H, et al. treated SCID mice
with CA1-pulsed regulatory dendritic cells. The treated
mice had higher mRNA expression of IL-10 and TGF-β1
and lower IL-17 mRNA expression [19].Conclusion
This study investigated the pathogenic role of CA1 using
a transgenic animal model. Transgenic mice that over-
expressed CA1 show an enhanced susceptibility to CIA.
Histochemistry and X-ray analysis also demonstrated
similar joint destruction to that found in AS. This find-
ing may provide additional understanding of the patho-
genic mechanism underlying the rheumatic disease.Abbreviations
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